Position in LLY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$48,794,718
-$15,566,798 QoQ
Shares Held
53,051
-11.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $579,743,845 across 13 Drug Manufacturers - General names. LLY ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
926,410 | $201,484,910 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
2,075,945 | $125,906,064 | |
| 3 | AMGN |
Amgen Inc
|
321,715 | $113,195,422 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
53,051 | $48,794,718 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
270,699 | $37,727,319 | |
| 6 | GSK |
GSK plc
|
425,687 | $23,493,665 | |
| 7 | MRK |
Merck & Co., Inc.
|
142,729 | $17,168,871 | |
| 8 | NVS |
Novartis AG
|
24,886 | $3,801,336 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,794,718 | 53,051 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $64,361,516 | 59,889 | Shares | Defined | 2026-02-12 | |
| 2025-06-30 | $21,348,988 | 27,387 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $6,575,896 | 8,518 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $186,055,373 | 210,009 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,627,873 | 1,798 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $12,314,328 | 15,829 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $14,966,471 | 25,675 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,083,670 | 13,188 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $779,444 | 1,662 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $111,898,942 | 325,837 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,013,217 | 5,503 | Shares | Defined | 2023-02-10 | |
| 2022-06-30 | $17,037,962 | 52,549 | Shares | Defined | 2022-08-12 | |
| 2021-09-30 | $5,829,160 | 25,229 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,962,601 | 56,477 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,549,158 | 13,645 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $25,067,483 | 169,352 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||